MCM
CLBTW

Moore Capital Management’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

Moore Capital Management’s Portfolio CLBTW Stock Details CLBTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-333,333
Closed -$587K – 873
2021
Q4 		$587K Hold
333,333
– – 0.01% 478
2021
Q3 		$717K Buy
+333,333
New +$767K 0.01% 531

Other funds holding CLBTW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
CPM
Crescent Park Management East Palo Alto, California $29M AUM 1.79% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

Moore Capital Management's CLBTW Position: Q1 2022 in Review

Moore Capital Management sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q1 2022, closing a stake of 333,333 shares — an estimated $587K sold.

Moore Capital Management first reported a position in CLBTW in Q3 2021 and held it in 2 quarters. The position peaked at $717K in Q3 2021. 26 funds tracked by Wall St. Rank hold CLBTW as of Q1 2022.

  • Moore Capital Management reported no remaining Cellebrite DI Ltd. Warrants position as of Q1 2022 after selling out during the quarter.
  • Moore Capital Management sold 333,333 Cellebrite DI Ltd. Warrants shares in Q1 2022, an estimated $587K.
  • Moore Capital Management first reported a position in Cellebrite DI Ltd. Warrants in Q3 2021 and held it in 2 quarters.
  • Moore Capital Management's Cellebrite DI Ltd. Warrants position peaked at $717K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q1 2022.

Based on Moore Capital Management's 13F filing for Q1 2022, filed 16 May 2022.